Novozymes and Sobrato Organisation were among the backers for life sciences-based venture firm Mission Bay Capital's oversubscribed second fund.
US-based venture capital firm Mission Bay Capital closed a $25m second fund featuring contributions from healthcare company Novozymes and commercial and residential real estate development company Sobrato Organisation yesterday.
Sobrato invested in MBC Fund II through its corporate venturing arm, Sobrato Capital, and the fund’s backers also included UCSF Foundation, the investment arm of University of California San Francisco, as well as William K Bowes Jr Foundation, real estate investor Capital Pacific, and undisclosed private investors.
MBC Fund II, which…